Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Century Acquisition Corporation was a special purpose acquisition company (SPAC) formed for the purpose of acquiring or merging with an operating business with primary operations in China. While the company initially targeted the healthcare and medical device sectors—most notably through a high-profile but ultimately terminated merger agreement with Amsino Medical Group in 2008—it eventually pivoted its focus. In 2010, the company completed a business combination with Ku6 Media, a leading Chinese internet video portal. Following the merger, the entity transitioned away from its original acquisition mandate and the healthcare sector entirely.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Century Acquisition.